Health X Platform share news, announcements and annual reports
NSE: HEALTHXBSE: 533259Healthcare ServicesSmall Cap
Health X Platform Limited · Formerly Sastasundar Ventures · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2010
Last close ₹289.50up ₹10.30 (3.69%)BSE ₹273.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹279.20.
30 Oct: open ₹282.00, high ₹292.75, low ₹274.95
52-week range of traded prices to 30 Oct 2026
₹252.50Low, 30 Mar 2026₹363.00High, 13 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹921 Cr1,526th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.44
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −9.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,52679.6% delivered
Health X Platform board meetings
113 filed, newest first. Page 3 of 3.
Aug 2013
5 Aug · Board meeting
To consider inter-alia the Un-Audited standalone and consolidated Financial Results of the Company for the First Quarter ended on June 30, 2013.
May 2013
16 May · Board meeting
Inter-alia to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2013.
Feb 2013
8 Feb · Board meeting
Jan 2013
31 Jan · Board meeting
Inter alia, To consider various business, including consideration and approval of the Unaudited Financial Results of the Company for the Third Quarter and nine months ended December 31, 2012.
Oct 2012
20 Oct · Board meeting
To consider inter-alia the Un-Audited Financial Results for the Second Quarter ended on September 30, 2012.
Jul 2012
23 Jul · Board meeting
To consider inter-alia the Un-Audited Financial Results for the First Quarter ended on June 30, 2012.
Jan 2012
31 Jan · Board meeting
To consider inter-alia the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2011.
Oct 2011
31 Oct · Board meeting
To consider inter-alia the Un-Audited Financial Results for the Second Quarter and half year ended September 30, 2011.
Jul 2011
25 Jul · Board meeting
To consider inter alia the Un-audited Financial Results for the first quarter ended June 30, 2011.
May 2011
17 May · Board meeting
To consider inter-alia the Audited Financial Results for the year ended on March 31, 2011.
Jan 2011
27 Jan · Board meeting
To consider inter-alia the Unaudited Financial Results for the 3rd Quarter and Nine Months ended on December 31, 2010.
Nov 2010
9 Nov · Board meeting
Board of Directors of the Company, at its meeting held on November 09, 2010, interalia, considered and approved the following: 1)Appointment of Dr.Gaurav Vallabh as an Additional Director (Independent) of the Company.The Board has appointed Dr. Vallabh as the Chairman of the Audit Committee of the Board of Directors. 2) The Board noted the appointment of Mr. Giridhar Dhelia as the Chief Financial Officer of the Company in place of Mr. Pankaj Kumar Kedia.1 Nov · Board meeting
To consider inter-alia the Un-Audited Financial Results for the Quarter and Half year ended on September 30, 2010.